240721 Circa Group AS - Press release - Increase of required capital until end 2026
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2024-07-21 18:15:00
Oslo, Norway- 21 July 2024 - Circa Group AS (ticker: CIRCA) has previously
reported that the company requires approximately EUR 40 million in new capital
to cover remaining capex and opex related to the construction and commissioning
of the ResoluteTM plant in North-East France to end 2025.
The current management has, following further developments in the project and
the company's business plan, reached the conclusion that the total need of
additional capital is approximately EUR 60 million to cover the total estimated
cost of completing the ReSoluteTM project and other Circa Group costs up to end
2026.
The company's management team and board of directors are diligently continuing
their efforts to raise the needed additional funding to complete the project and
will provide updates on the process in due time.
About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food biomass and addressing a gap in the market by
providing bio-based, less carbon intensive alternatives, contributing to a more
circular economy. https://circa-group.com
This announcement was published by Jens Even Højlund Pedersen, General Counsel,
on 21 July 2024.
Investor Contact
Erik Berger
CFO
Circa Group AS
Erik.berger@circa-group.com
Tel: +47 908 55 033